These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9633000)
1. Can HIV be eradicated? Pantaleo G; Perrin L AIDS; 1998; 12 Suppl A():S175-80. PubMed ID: 9633000 [No Abstract] [Full Text] [Related]
2. [New biological monitoring of HIV infection]. Morand-Joubert L Rev Prat; 1998 Mar; 48(5):472-7. PubMed ID: 9781107 [No Abstract] [Full Text] [Related]
3. Understanding the principles of anti-HIV drug therapy. Horn T Surviv News (Atlanta Ga); 2001 Jul; ():13. PubMed ID: 11683014 [No Abstract] [Full Text] [Related]
4. Immune activation and the pathogenesis of HIV disease: implications for therapy. Fernandez S; Lim A; French M J HIV Ther; 2009 Nov; 14(3):52-6. PubMed ID: 20218239 [No Abstract] [Full Text] [Related]
5. Ongoing HIV dissemination during HAART. Grossman Z; Polis M; Feinberg MB; Grossman Z; Levi I; Jankelevich S; Yarchoan R; Boon J; de Wolf F; Lange JM; Goudsmit J; Dimitrov DS; Paul WE Nat Med; 1999 Oct; 5(10):1099-104. PubMed ID: 10502799 [No Abstract] [Full Text] [Related]
6. Mutation and control of the human immunodeficiency virus. Stengel RF Math Biosci; 2008 Jun; 213(2):93-102. PubMed ID: 18439629 [TBL] [Abstract][Full Text] [Related]
7. HAART version 2.0. Huff B GMHC Treat Issues; 2002 Mar; 16(3):1-4. PubMed ID: 12004795 [No Abstract] [Full Text] [Related]
8. HIV eradication theory meets reality. TreatmentUpdate; 1999 May; 11(3):3. PubMed ID: 11366779 [TBL] [Abstract][Full Text] [Related]
9. Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy. Dufour V; Wislez M; Bergot E; Mayaud C; Cadranel J Clin Infect Dis; 2003 May; 36(10):e127-30. PubMed ID: 12746792 [TBL] [Abstract][Full Text] [Related]
10. Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy. Sarmati L; Nicastri E; Montano M; Dori L; Buonomini AR; d'Ettorre G; Gatti F; Parisi SG; Vullo V; Andreoni M J Med Virol; 2004 Apr; 72(4):511-6. PubMed ID: 14981751 [TBL] [Abstract][Full Text] [Related]
11. [German-Austrian guidelines for antiretroviral therapy of HIV infection. (July, 2002, update)]. Brockmeyer NH; ; Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S7-18. PubMed ID: 12736863 [No Abstract] [Full Text] [Related]
13. Long-term suppression of HIV replication in patients with sustained benefit on zidovudine monotherapy. Gómez-Cano M; Soriano V; Pérez-Olmeda M; Machuca A; Rodríguez-Rosado R; Valencia E; Moreno V; Gutiérrez M; González-Lahoz J AIDS; 1998 May; 12(8):964-6. PubMed ID: 9631158 [No Abstract] [Full Text] [Related]
14. [HIV infection. Virus resistance: development and prevention]. Link R; Miller V; Fätkenheuer G; Manegold C; Harrer T Med Monatsschr Pharm; 1999 Mar; 22(3):86-8. PubMed ID: 10223868 [No Abstract] [Full Text] [Related]
15. New perspectives on HIV pathogenesis. Viral replication is continuous throughout the course of disease. J Assoc Nurses AIDS Care; 1995; 6(5):26-7. PubMed ID: 8785413 [No Abstract] [Full Text] [Related]
16. IL-2 taken to HAART. Gilden D GMHC Treat Issues; 1999 Feb; 13(2):4-6. PubMed ID: 11366116 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 and HAART: a time to cure, a time to kill. Saag MS; Kilby JM Nat Med; 1999 Jun; 5(6):609-11. PubMed ID: 10371490 [No Abstract] [Full Text] [Related]
18. Anti-HIV agents. Can valproic acid help flush HIV from hiding? TreatmentUpdate; 2005; 17(6):4-5. PubMed ID: 17228475 [No Abstract] [Full Text] [Related]
19. [Viral dynamics in the course of HIV-1 infection: pathogenetic features and new therapeutic prospects]. Marcello A; Giacca M Pathologica; 2000 Aug; 92(4):291-3. PubMed ID: 11029891 [No Abstract] [Full Text] [Related]
20. HIV replication. Kingman S Mol Med Today; 1995 Apr; 1(1):2. PubMed ID: 9415128 [No Abstract] [Full Text] [Related] [Next] [New Search]